Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial
Indian Journal of Medical Specialities · 2026-07 · 17 (3) · 213-217
DOI: 10.4103/injms.injms_2_26 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Medical Specialities, online erschienen am 06.07.2026. Verfasst von Sanjay Meena und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Neonatal hyperbilirubinemia is a common condition in the early neonatal period and, if severe, may result in bilirubin-induced neurological dysfunction. Phototherapy is the standard treatment; however, prolonged therapy is associated with increased hospital stay and potential adverse effects. Zinc has been proposed as an adjunct therapy due to its ability to inhibit enterohepatic circulation of bilirubin.
Objectives
To evaluate the effect of oral zinc supplementation in reduction of serum bilirubin levels in term neonates undergoing phototherapy and to compare the duration of phototherapy and hospital stay between zinc-supplemented and placebo groups. Materials and Methods: This randomized controlled trial was conducted in the Department of Paediatrics, Dr. S. N. Medical College, Jodhpur, from March to May 2025. A total of 100 term neonates with hyperbilirubinemia requiring phototherapy were randomized into two groups: zinc group ( n = 50) receiving 5 mg oral zinc sulfate daily and placebo group ( n = 50) receiving 5% dextrose, alongside standard phototherapy. Serum bilirubin levels were measured at baseline, 24, 48, and 72 h. Duration of phototherapy and hospital stay were recorded. Statistical analysis was performed using SPSS version 22.
Results
Baseline characteristics were comparable between the groups. The zinc group showed significantly greater reductions in serum bilirubin levels at 24, 48, and 72 h compared to the placebo group ( P < 0.001). Mean duration of phototherapy (47.7 ± 6.4 vs. 59.6 ± 6.4 h) and hospital stay (2.9 ± 0.4 vs. 3.5 ± 0.6 days) were significantly shorter in the zinc group ( P < 0.001).
Conclusion
Oral zinc supplementation is a safe and effective adjunct to phototherapy in term neonates, resulting in faster bilirubin reduction and decreased treatment duration.
Zitieren
APA
Meena, S., Bijarnia, R., Choudhary, K., & Choudhary, S. (2026). Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Journal of Medical Specialities, 17(3), 213-217. https://doi.org/10.4103/injms.injms_2_26
Vancouver
Meena S, Bijarnia R, Choudhary K, Choudhary S. Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Journal of Medical Specialities. 2026;17(3):213-217. doi:10.4103/injms.injms_2_26
BibTeX
@article{Meena2026,
author = {Meena, Sanjay and Bijarnia, Ritu and Choudhary, Kannupriya and Choudhary, Sandeep},
title = {Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial},
journal = {Indian Journal of Medical Specialities},
year = {2026},
volume = {17},
number = {3},
pages = {213--217},
doi = {10.4103/injms.injms_2_26}
}
EUVIMED